Use of a clinical decision support system to increase osteoporosis screening: how similar is the historical control?

, , &
Journal of Evaluation in Clinical Practice 18 (4):925-925 (2012)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1111/j.1365-2753.2012.01872.x

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,438

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Use of a clinical decision support system to increase osteoporosis screening.Ramona S. DeJesus - 2012 - Journal of Evaluation in Clinical Practice 18 (4):926-926.
'If it was osteoporosis, I would have really hurt myself.' Ambiguity about osteoporosis and osteoporosis care despite a screening programme to educate fragility fracture patients.Joanna E. M. Sale, Dorcas E. Beaton, Rebeka Sujic & Earl R. Bogoch - 2010 - Journal of Evaluation in Clinical Practice 16 (3):590-596.
Impact of a community pharmacist‐directed clinic in improving screening and awareness of osteoporosis.Anandi V. Law & Karen Shapiro - 2005 - Journal of Evaluation in Clinical Practice 11 (3):247-255.
Use of a Web-based clinical decision support system to improve abdominal aortic aneurysm screening in a primary care practice.Rajeev Chaudhry, Sidna M. Tulledge-Scheitel, Doug A. Parks, Kurt B. Angstman, Lindsay K. Decker & Robert J. Stroebel - 2012 - Journal of Evaluation in Clinical Practice 18 (3):666-670.
Can safety assurance procedures in the food industry be used to evaluate a medical screening programme? The application of the Hazard Analysis and Critical Control Point system to an antenatal serum screening programme for Down's syndrome. Stage 2: overcoming the hazards in programme delivery.M. Clare Derrington, Elizabeth S. Draper, Ronald T. Hsu & Jennifer J. Kurinczuk - 2003 - Journal of Evaluation in Clinical Practice 9 (1):49-57.
Can safety assurance procedures in the food industry be used to evaluate a medical screening programme? The application of the Hazard Analysis and Critical Control Point system to an antenatal serum screening programme for Down's syndrome. Stage 1: identifying significant hazards.M. Clare Derrington, Janet D. Glencross, Elizabeth S. Draper, Ronald T. Hsu & Jennifer J. Kurinczuk - 2003 - Journal of Evaluation in Clinical Practice 9 (1):39-47.
Breast cancer screening in younger women: evidence and decision making.J. Mark Elwood - 1997 - Journal of Evaluation in Clinical Practice 3 (3):179-186.
The fracture and osteoporosis outpatient clinic: an effective strategy for improving implementation of an osteoporosis guideline.Svenhjalmar van Helden, Evelyne Cauberg, Piet Geusens, Bjorn Winkes, Trudy van der Weijden & Peter Brink - 2007 - Journal of Evaluation in Clinical Practice 13 (5):801-805.
Perspectives on the ethical concerns and justifications of the 2006 Centers for Disease Control and Prevention HIV testing: HIV screening policy changes.Michael J. Waxman, Roland C. Merchant, M. T. Celada & Melissa A. Clark - 2013 - BMC Medical Ethics 14 (1):46.
Improving rates of herpes zoster vaccination with a clinical decision support system in a primary care practice.Rajeev Chaudhry, Sidna M. Schietel, Fred North, Ramona Dejesus, Rebecca L. Kesman & Robert J. Stroebel - 2013 - Journal of Evaluation in Clinical Practice 19 (2):263-266.
Review and evaluation of the Dutch guidelines for osteoporosis.Piet P. Geusens, Willem F. Lems, Harald J. J. Verhaar, Geraline Leusink, Stefan Goemaere, Hans Zmierczack & Jullet Compston - 2006 - Journal of Evaluation in Clinical Practice 12 (5):539-548.
Effect of visit length and a clinical decision support tool on abdominal aortic aneurysm screening rates in a primary care practice.John Eaton, Darcy Reed, Kurt B. Angstman, Kris Thomas, Frederick North, Robert Stroebel, Sidna M. Tulledge-Scheitel & Rajeev Chaudhry - 2012 - Journal of Evaluation in Clinical Practice 18 (3):593-598.
Suboptimal vitamin D screening in older patients with compromised skeletal health.Nahid J. Rianon, Kathleen P. Murphy, Rodrigo Guanlao, Matthew Hnatow, Elaine De Leon & Beatrice J. Selwyn - 2014 - Journal of Evaluation in Clinical Practice 20 (2):144-148.
Patterns of osteoporosis treatment change and treatment discontinuation among commercial and Medicare Advantage Prescription Drug members in a national health plan.Yihua Xu, Hema N. Viswanathan, Melea A. Ward, Brad Clay, John L. Adams, Bradley S. Stolshek, Joel D. Kallich, Shari Fine & Kenneth G. Saag - 2013 - Journal of Evaluation in Clinical Practice 19 (1):50-59.
Consenting to uncertainty: Challenges for informed consent to disease screening—a case study.Mark Greene & Suzanne M. Smith - 2008 - Theoretical Medicine and Bioethics 29 (6):371-386.

Analytics

Added to PP
2013-11-24

Downloads
45 (#347,159)

6 months
4 (#793,623)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

Use of a clinical decision support system to increase osteoporosis screening.Ramona S. DeJesus - 2012 - Journal of Evaluation in Clinical Practice 18 (4):926-926.

Add more references